Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.

Rezende BM, Athayde RM, Gonçalves WA, Resende CB, Teles de Tolêdo Bernardes P, Perez DA, Esper L, Reis AC, Rachid MA, Castor MGME, Cunha TM, Machado FS, Teixeira MM, Pinho V.

J Exp Med. 2017 Nov 6;214(11):3399-3415. doi: 10.1084/jem.20170261. Epub 2017 Sep 25.

2.

Erratum: Noninvasive Ventilation in Newborns ≤ 1,500 g after Tracheal Extubation: Randomized Clinical Trial.

Ribeiro SNS, Fontes MJF, Bhandari V, Resende CB, Johnston C.

Am J Perinatol. 2017 Oct;34(12):e1-e2. doi: 10.1055/s-0037-1603350. Epub 2017 May 10. No abstract available.

PMID:
28493239
3.

Noninvasive Ventilation in Newborns ≤ 1,500 g after Tracheal Extubation: Randomized Clinical Trial.

Ribeiro SNS, Fontes MJF, Bhandari V, Resende CB, Johnston C.

Am J Perinatol. 2017 Oct;34(12):1190-1198. doi: 10.1055/s-0037-1602141. Epub 2017 Apr 18. No abstract available.

PMID:
28420011
4.

Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.

Resende CB, Rezende BM, Bernardes PT, Teixeira GM, Teixeira MM, Pinho V, Bittencourt H.

Braz J Med Biol Res. 2017 Feb 9;50(2):e5566. doi: 10.1590/1414-431X20165566.

5.

EVALUATION OF PRIMARY PROPHYLAXIS WITH PROPRANOLOL AND ELASTIC BAND LIGATION IN VARICEAL BLEEDING IN CIRRHOTIC CHILDREN AND ADOLESCENTS.

Pimenta JR, Ferreira AR, Bittencourt PF, Resende CB, Fagundes ED, Silva IM.

Arq Gastroenterol. 2016 Oct-Dec;53(4):257-261. doi: 10.1590/S0004-28032016000400009.

6.

Factors Associated With Bleeding Secondary to Rupture of Esophageal Varices in Children and Adolescents With Cirrhosis.

Pimenta JR, Ferreira AR, Fagundes ED, Queiroz TC, Baptista RA, de Araújo Moreira EG, de Resende CB, Bittencourt PF, Carvalho SD, Neto JA, Penna FJ.

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):e44-e48. doi: 10.1097/MPG.0000000000001362.

PMID:
27496799
7.

Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.

Cruz BF, Resende CB, Carvalhaes CF, Cardoso CS, Teixeira AL, Keefe RS, Rocha FL, Salgado JV.

Rev Bras Psiquiatr. 2016 Jul-Sep;38(3):216-21. doi: 10.1590/1516-4446-2015-1776. Epub 2016 Jun 14.

8.

Evaluation of the improvement of quality of life with Azithromycin in the treatment of eosinophilic nasal polyposis.

Oliveira IS, Crosara PF, Cassali GD, Reis DC, Resende CB, Nunes FB, Guimarães RE.

Braz J Otorhinolaryngol. 2016 Mar-Apr;82(2):198-202. doi: 10.1016/j.bjorl.2015.03.018. Epub 2015 Sep 21.

9.

Power reflectance testing in newborns and infants.

Lima TG, Becker HM, Becker CG, Ferreira DB, Resende CB, Guimarães RE.

Braz J Otorhinolaryngol. 2015 Nov-Dec;81(6):610-5. doi: 10.1016/j.bjorl.2015.08.008. Epub 2015 Sep 7.

10.

Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia).

Araújo GE, Resende CB, Cardoso AC, Teixeira AL, Keefe RS, Salgado JV.

Clinics (Sao Paulo). 2015 Apr;70(4):278-82. doi: 10.6061/clinics/2015(04)10.

11.

Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects.

Bernardes PT, Rezende BM, Resende CB, De Paula TP, Reis AC, Gonçalves WA, Vieira EG, Pinheiro MV, Souza DG, Castor MG, Teixeira MM, Pinho V.

PLoS One. 2015 Apr 13;10(4):e0123004. doi: 10.1371/journal.pone.0123004. eCollection 2015.

12.

Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.

Rezende BM, Bernardes PT, Resende CB, Arantes RM, Souza DG, Braga FC, Castor MG, Teixeira MM, Pinho V.

Mar Drugs. 2013 Jul 18;11(7):2595-615. doi: 10.3390/md11072595.

13.

How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.

Cruz BF, de Resende CB, Abreu MN, Rocha FL, Teixeira AL, Keefe RS, Salgado JV.

Cogn Neuropsychiatry. 2013 May;18(3):243-51. doi: 10.1080/13546805.2012.730995. Epub 2012 Nov 12.

PMID:
23145794
14.

Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality.

Castor MG, Rezende BM, Resende CB, Bernardes PT, Cisalpino D, Vieira AT, Souza DG, Silva TA, Teixeira MM, Pinho V.

J Leukoc Biol. 2012 Apr;91(4):629-39. doi: 10.1189/jlb.1111561. Epub 2012 Feb 1.

PMID:
22301794
15.

The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice.

Castor MG, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, Arantes RM, Souza DG, Silva TA, Proudfoot AE, Teixeira MM, Pinho V.

J Immunol. 2010 Mar 1;184(5):2646-54. doi: 10.4049/jimmunol.0902614. Epub 2010 Jan 25.

Supplemental Content

Loading ...
Support Center